Results for this period
Full year1 October 2025 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Net sales increased, mainly because a large-scale electronic medical record system project went live during the current fiscal year, and operating profit and ordinary profit also increased in line with the higher sales. Net profit declined because the gain on the partial sale of Micron shares recorded in the previous fiscal year was absent and an impairment loss was recognized on “Doctor Connect” during the current fiscal year.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 September 2026 |
| Net Sales | ¥16,173 million (YoY +2.2%) |
| Operating profit | ¥1,447 million (YoY +2.6%) |
| Ordinary income | ¥1,481 million (YoY +3.9%) |
| Profit attributable to owners of the parent | ¥756 million (YoY -51.4%) |
| Net income per share | ¥45.40 |
| Operating Margin | 9.0% |
| Equity ratio | End of the current fiscal period 72.1% / End of previous period 65.2% |
| Total assets | ¥11,410 million |
| Net assets | ¥8,778 million |
| Cash flows from operating activities | ¥2,177 million |
| Cash flows from investing activities | ¥-812 million |
| Cash flows from financing activities | ¥-1,518 million |
| Cash and cash equivalents at end of period | ¥4,880 million |
| Annual Dividend Forecast | ¥52 → ¥0（-100.0%） |
| Segment revenue | Healthcare Solutions business ¥15,684 million (YoY +2.3%), Marketing Solutions Business ¥488 million (YoY -2.7%) |
| Segment profit | Healthcare Solutions business ¥1,608 million (YoY +10.6%), Marketing Solutions Business ¥17 million |
| Orders received and order backlog | Orders received ¥13,997 million / Order backlog ¥4,152 million |
| Depreciation and amortization | ¥588 million |
| Impairment loss | ¥148,467 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not applicable / Extraordinary loss Impairment losses ¥148,467 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not applicable |
| Material subsequent events | The company resolved to carry out a share consolidation, abolish the share-unit designation, partially amend its Articles of Incorporation, and cancel treasury shares. Accordingly, the company’s shares are scheduled to be delisted on 13 January 2027. |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 17,039,400 shares |
| Treasury Shares at Period-End | 363,863 shares |
| Factors Behind Changes in Business Performance | Net sales increased, mainly because a large-scale electronic medical record system project went live during the current fiscal year, and operating profit and ordinary profit also increased in line with the higher sales. Net profit declined because the gain on the partial sale of Micron shares recorded in the previous fiscal year was absent and an impairment loss was recognized on “Doctor Connect” during the current fiscal year. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales, operating profit and ordinary profit increased, mainly because a large-scale electronic medical record system project went live during the current fiscal year. However, profit attributable to owners of the parent declined because a gain on the partial sale of Micron shares had been recorded in the previous fiscal year and an impairment loss was recognized on the smartphone service “Doctor Connect” during the current fiscal year.